Get the Stockscreener App
1.57
3.29%
0.05
After Hours:
1.56
-0.01
-0.64%
MAIA Biotechnology Inc stock is traded at $1.57, with a volume of 548.99K.
It is up +3.29% in the last 24 hours and down -6.55% over the past month.
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.
See More
Previous Close:
$1.52
Open:
$1.59
24h Volume:
548.99K
Relative Volume:
1.16
Market Cap:
$51.80M
Revenue:
-
Net Income/Loss:
$-25.94M
P/E Ratio:
-1.1377
EPS:
-1.38
Net Cash Flow:
$-15.79M
1W Performance:
-9.25%
1M Performance:
-6.55%
6M Performance:
+4.67%
1Y Performance:
-42.07%
1-Day Range:
$1.5201
$1.59
1-Week Range:
$1.51
$1.97
52-Week Range:
$1.40
$3.48
MAIA Biotechnology Inc Stock (MAIA) Company Profile
Name
MAIA Biotechnology Inc
Sector
Industry
Phone
312 416 8592
Address
444 West Lake Street, Suite 1700, Chicago
Compare MAIA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.57 | 50.15M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
MAIA Biotechnology Inc Stock (MAIA) Latest News
Maia biotechnology announces $736,600 private placement - MarketScreener
MAIA Biotechnology announces $0.74M private placement - MSN
MAIA Biotechnology raises $736,600 in private placement By Investing.com - Investing.com Canada
MAIA Biotechnology Announces $736,600 Private Placement - The Manila Times
$736,600 Private Placement — MAIA Biotechnology to fund Step 1 of Phase II THIO-101; warrants issued - Stock Titan
How strong is MAIA Biotechnology Inc. stock balance sheet2025 Volume Leaders & Fast Gain Swing Trade Alerts - newser.com
Best data tools to analyze MAIA Biotechnology Inc. stock2025 Major Catalysts & Verified High Yield Trade Plans - newser.com
Analyzing net buyer seller activity in MAIA Biotechnology Inc.Gap Down & Fast Moving Stock Watchlists - newser.com
Is MAIA Biotechnology Inc. stock a smart buy before Fed meeting2025 Market Overview & Real-Time Volume Analysis Alerts - newser.com
Is MAIA Biotechnology Inc. meeting your algorithmic filter criteriaJuly 2025 Final Week & Verified Momentum Stock Watchlist - newser.com
Can swing trading help recover from MAIA Biotechnology Inc. lossesWeekly Market Summary & Expert-Curated Trade Recommendations - newser.com
Evaluating MAIA Biotechnology Inc. with trendline analysisJuly 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
Is MAIA Biotechnology Inc. building a consolidation base2025 Short Interest & Capital Efficiency Focused Ideas - newser.com
Why analysts maintain buy rating on MAIA Biotechnology Inc. stockMarket Activity Recap & Weekly Sector Rotation Insights - newser.com
Ranking MAIA Biotechnology Inc. among high performing stocks via toolsJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Can MAIA Biotechnology Inc. stock weather global recessionPortfolio Risk Report & Weekly High Potential Alerts - newser.com
How geopolitical tensions affect MAIA Biotechnology Inc. stockPortfolio Value Summary & Weekly Watchlist of Top Performers - newser.com
Published on: 2025-10-10 04:31:13 - newser.com
Risk adjusted return profile for MAIA Biotechnology Inc. analyzed2025 Investor Takeaways & Daily Price Action Insights - newser.com
Can technical indicators confirm MAIA Biotechnology Inc.’s reversalJuly 2025 Selloffs & Verified High Yield Trade Plans - newser.com
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 3.5%What's Next? - MarketBeat
MAIA Biotechnology Announces $2.25M Private Placement Deal - MSN
MAIA Biotechnology moves 90% of treasury into crypto assets - Traders Union
Biotech Giant MAIA Biotechnology (NYSE American: MAIA) Dives Headfirst into Crypto with Audacious Treasury Strategy - FinancialContent
MAIA Biotechnology Adopts New Digital Asset Strategy - TipRanks
MAIA Biotechnology to hold up to 90% of liquid assets in crypto - Seeking Alpha
MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto Assets - The Manila Times
MAIA Biotechnology, Inc. Approves Up to 90% Liquid Asset Holdings in Cryptocurrencies as Part of New Digital Asset Treasury Strategy - Quiver Quantitative
MAIA Biotechnology Inc. stock retracement – recovery analysisAnalyst Downgrade & Low Risk Profit Maximizing Plans - newser.com
Multi asset correlation models including MAIA Biotechnology Inc.Quarterly Profit Summary & Short-Term Trading Alerts - newser.com
What hedge fund moves indicate for MAIA Biotechnology Inc. stockGlobal Markets & Fast Gain Stock Tips - newser.com
Developing predictive dashboards with MAIA Biotechnology Inc. data2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com
Published on: 2025-10-05 01:56:41 - newser.com
Custom strategy builders for tracking MAIA Biotechnology Inc.2025 Investor Takeaways & Weekly Consistent Profit Watchlists - newser.com
MAIA Biotechnology (NYSEAMERICAN:MAIA) Director Stan Smith Acquires 19,230 Shares - MarketBeat
MAIA Biotechnology Inc Stock (MAIA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Cap:
|
Volume (24h):